A detailed history of Cutler Group LP transactions in Morpho Sys Ag stock. As of the latest transaction made, Cutler Group LP holds 14,700 shares of MOR stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,700
Previous 8,000 83.75%
Holding current value
$0
Previous $79,000 100.0%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 18, 2024

BUY
$4.55 - $9.9 $36,076 - $78,497
7,929 Added 11167.61%
8,000 $79,000
Q3 2023

Nov 07, 2023

BUY
$6.72 - $8.6 $477 - $610
71 New
71 $0

Others Institutions Holding MOR

About MorphoSys AG


  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.